BioCentury | Dec 2, 2020
Distillery Therapeutics

Inhibiting vesicular trafficking protein SURF4 to treat atherosclerosis

...et al. Cell Metab.; published online Nov. 12, 2020doi:10.1016/j.cmet.2020.10.020CONTACT: Xiao-Wei Chen, Peking University, Beijing, Chinaemail: xiaowei_chen@pku.edu.cn Claire Quang Peking University Cardiovascular Atherosclerosis...
BioCentury | Nov 6, 2020
Management Tracks

BeiGene’s pathfinding CFO Liang to retire

...Los Angeles and Shanghai Jia Tong University, and the other between University of Oxford and Peking University...
BioCentury | Sep 22, 2020
Management Tracks

Recent crackdowns on export regulations in China may provide clues into ongoing GenScript investigations

...Los Angeles and Shanghai Jia Tong University, and the other between University of Oxford and Peking University...
BioCentury | Sep 9, 2020
Politics & Policy

Impact of China’s export restrictions on biopharma dealmaking likely limited, at least for now

...of California Los Angeles (UCLA) and Shanghai Jia Tong University, and University of Oxford and Peking University...
BioCentury | Apr 8, 2020
Finance

Suzhou Ribo raises $66.3M for nucleic acid therapies

...Ribo was founded in 2007 by Chairman Zicai Liang, an siRNA researcher and professor at Peking University...
BioCentury | Jan 31, 2020
Distillery Therapeutics

FERMT2 identified as target in renal fibrosis

...J. et al. Cell Rep. ; published online Dec. 10, 2019 doi:10.1016/j.celrep.2019.11.035 CONTACT: Jun Zhan, Peking University...
...Science Center, Beijing, China email: zhanjun@bjmu.edu.cn CONTACT: Hongquan Zhang, same affiliation as above email: hongquan.zhang@bjmu.edu.cn Claire Quang Peking University Fermitin...
BioCentury | Dec 18, 2019

The proteasome-regulating kinase DYRK2 as a target in breast cancer and multiple myeloma

...E. Dixon, University of California San Diego, La Jolla, Calif. email: jedixon@ucsd.edu CONTACT: Junyu Xiao, Peking University...
...email: junyuxiao@pku.edu.cn CONTACT: Xiaoguang Lei, same affiliation as above email: xglei@pku.edu.cn Claire Quang University of California San Diego Peking University...
BioCentury | Oct 15, 2019
Politics & Policy

Protests delay Hong Kong biotech conference

...academic and industry leaders and mainland China government representatives including Qi Min Zhan, EVP of Peking University...
BioCentury | Aug 8, 2019
Distillery Therapeutics

Endocytosis protein decoy for reducing TRPV1-associated pain

...published online Jun. 11, 2019 doi:10.1126/scisignal.aaw2040 CONTACT: Yun Wang, Peking University, Beijing, China e-mail: wangy66@bjmu.edu.cn Sandi Wong Peking University Cyclin...
BioCentury | Jul 25, 2019
Distillery Therapeutics

A tumor-targeted Bavencio conjugate with enhanced antitumor efficacy

...Research (Calibr); The Scripps Research Institute, La Jolla, Calif. e-mail: schultz@scripps.edu CONTACT: Yu J. Cao, Peking University...
Items per page:
1 - 10 of 80
BioCentury | Dec 2, 2020
Distillery Therapeutics

Inhibiting vesicular trafficking protein SURF4 to treat atherosclerosis

...et al. Cell Metab.; published online Nov. 12, 2020doi:10.1016/j.cmet.2020.10.020CONTACT: Xiao-Wei Chen, Peking University, Beijing, Chinaemail: xiaowei_chen@pku.edu.cn Claire Quang Peking University Cardiovascular Atherosclerosis...
BioCentury | Nov 6, 2020
Management Tracks

BeiGene’s pathfinding CFO Liang to retire

...Los Angeles and Shanghai Jia Tong University, and the other between University of Oxford and Peking University...
BioCentury | Sep 22, 2020
Management Tracks

Recent crackdowns on export regulations in China may provide clues into ongoing GenScript investigations

...Los Angeles and Shanghai Jia Tong University, and the other between University of Oxford and Peking University...
BioCentury | Sep 9, 2020
Politics & Policy

Impact of China’s export restrictions on biopharma dealmaking likely limited, at least for now

...of California Los Angeles (UCLA) and Shanghai Jia Tong University, and University of Oxford and Peking University...
BioCentury | Apr 8, 2020
Finance

Suzhou Ribo raises $66.3M for nucleic acid therapies

...Ribo was founded in 2007 by Chairman Zicai Liang, an siRNA researcher and professor at Peking University...
BioCentury | Jan 31, 2020
Distillery Therapeutics

FERMT2 identified as target in renal fibrosis

...J. et al. Cell Rep. ; published online Dec. 10, 2019 doi:10.1016/j.celrep.2019.11.035 CONTACT: Jun Zhan, Peking University...
...Science Center, Beijing, China email: zhanjun@bjmu.edu.cn CONTACT: Hongquan Zhang, same affiliation as above email: hongquan.zhang@bjmu.edu.cn Claire Quang Peking University Fermitin...
BioCentury | Dec 18, 2019

The proteasome-regulating kinase DYRK2 as a target in breast cancer and multiple myeloma

...E. Dixon, University of California San Diego, La Jolla, Calif. email: jedixon@ucsd.edu CONTACT: Junyu Xiao, Peking University...
...email: junyuxiao@pku.edu.cn CONTACT: Xiaoguang Lei, same affiliation as above email: xglei@pku.edu.cn Claire Quang University of California San Diego Peking University...
BioCentury | Oct 15, 2019
Politics & Policy

Protests delay Hong Kong biotech conference

...academic and industry leaders and mainland China government representatives including Qi Min Zhan, EVP of Peking University...
BioCentury | Aug 8, 2019
Distillery Therapeutics

Endocytosis protein decoy for reducing TRPV1-associated pain

...published online Jun. 11, 2019 doi:10.1126/scisignal.aaw2040 CONTACT: Yun Wang, Peking University, Beijing, China e-mail: wangy66@bjmu.edu.cn Sandi Wong Peking University Cyclin...
BioCentury | Jul 25, 2019
Distillery Therapeutics

A tumor-targeted Bavencio conjugate with enhanced antitumor efficacy

...Research (Calibr); The Scripps Research Institute, La Jolla, Calif. e-mail: schultz@scripps.edu CONTACT: Yu J. Cao, Peking University...
Items per page:
1 - 10 of 80